E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with S
>
Issuers starting with S, CV only
>
All stories on Sciele Pharma, Inc.
>
Stories on Sciele Pharma, Inc., CV only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Sciele Pharma, Inc.
9/8/2008
CV
Sciele says its 2.625% notes are convertible in connection with Shionogi merger
9/5/2008
CV
Market Commentary:
AIG, Wachovia reverse losses; Transocean adds; SanDisk climbs on M&A chatter; Schiele Pharma trades
9/2/2008
CV
Market Commentary:
Chesapeake Energy mixed to slightly better as oil falls; Gilead eases; Sciele gains on buyout bid
1/11/2008
CV
Market Commentary:
Countrywide active on BofA buyout; WaMu up on rumored deal; Sciele, Mylan up in search for safety
10/17/2007
CV
Market Commentary:
Yahoo! says Yippee; Intel up on earnings; SanDisk rides tech wave; Countrywide down; CIT coming to play
6/15/2007
CV
Sciele: all $150 million of 1.75% notes converted ahead of redemption
5/15/2007
CV
Sciele calls all 1.75% convertibles
5/14/2007
CV
Sciele greenshoe fully exercised to push 2.625% convertibles issue to $325 million
5/9/2007
CV
New Issue: Sciele prices upsized $285 million 20-year convertibles within talk at 2.625%, up 47.5%
5/9/2007
CV
Market Commentary:
Chemed, Sciele soar in debuts; Alesco quiet in gray, Chesapeake draws mixed views; CACI, L-1 plan deals
5/8/2007
CV
Market Commentary:
Armor holds firm on merger hopes; Chemed higher, Sciele quiet in gray; Chesapeake, Alesco launch deals
5/8/2007
CV
Sciele talks $250 million 20-year convertibles at 2.375%-2.875%, up 45%-50%, to price Tuesday
5/8/2007
CV
Sciele to redeem 1.75% convertibles with new deal proceeds
7/25/2006
BTCV
Sciele reaches agreement with Nasdaq over rule compliance for exchanged convertible notes
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.